Composition for Prognosis and neoadjuvant chemoradiotherapy response prediction of rectal cancer and method and composition thereof for identification of extremely poor risk patients after standard neoadjuivant chemoradiotherapy in rectal cancer

摘要

The present invention relates to a biomarker composition for predicting the prognosis of a cancer patient, comprising a first molecular subtype or a protein transcribed and translated therefrom. In addition, the present invention relates to a biomarker composition for predicting the prognosis of a cancer patient, further comprising a second molecular subtype or a protein transcribed and translated therefrom.